×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NGNE – neurogene inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NGNE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/3
04:11 pm
ngne
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/3
04:01 pm
ngne
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/27
01:33 pm
ngne
Neurogene (NGNE) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $200.00 price target on the stock.
Medium
Report
Neurogene (NGNE) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $200.00 price target on the stock.
2/26
04:14 pm
ngne
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome [Yahoo! Finance]
High
Report
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome [Yahoo! Finance]
2/26
04:01 pm
ngne
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
High
Report
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
2/5
07:30 am
ngne
Neurogene to Participate in Upcoming Investor Conferences
Medium
Report
Neurogene to Participate in Upcoming Investor Conferences
2/4
04:01 pm
ngne
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1/26
09:26 am
ngne
Neurogene (NASDAQ:NGNE) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Neurogene (NASDAQ:NGNE) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $50.00 price target on the stock.
Date
Time
Symbol
Headline
Impact
3/3
05:04 pm
ngne
Form 4 Neurogene Inc. For: Feb 27 Filed by: Cvijic Christine Mikail
Medium
Report
Form 4 Neurogene Inc. For: Feb 27 Filed by: Cvijic Christine Mikail
2/27
04:51 pm
ngne
Form 144 Neurogene Inc. Filed by: Cvijic Christine Mikail
High
Report
Form 144 Neurogene Inc. Filed by: Cvijic Christine Mikail
2/26
04:02 pm
ngne
Form 8-K Neurogene Inc. For: Feb 26
High
Report
Form 8-K Neurogene Inc. For: Feb 26
2/24
06:50 pm
ngne
Form 4 Neurogene Inc. For: Feb 20 Filed by: Cobb Stuart
Medium
Report
Form 4 Neurogene Inc. For: Feb 20 Filed by: Cobb Stuart
2/24
06:49 pm
ngne
Form 4 Neurogene Inc. For: Feb 20 Filed by: Cvijic Christine Mikail
Medium
Report
Form 4 Neurogene Inc. For: Feb 20 Filed by: Cvijic Christine Mikail
2/24
06:49 pm
ngne
Form 4 Neurogene Inc. For: Feb 20 Filed by: Jordan Julie
Medium
Report
Form 4 Neurogene Inc. For: Feb 20 Filed by: Jordan Julie
2/24
06:48 pm
ngne
Form 4 Neurogene Inc. For: Feb 20 Filed by: PALEKAR ROHAN
Medium
Report
Form 4 Neurogene Inc. For: Feb 20 Filed by: PALEKAR ROHAN
2/24
06:48 pm
ngne
Form 4 Neurogene Inc. For: Feb 20 Filed by: McMinn Rachel
Medium
Report
Form 4 Neurogene Inc. For: Feb 20 Filed by: McMinn Rachel
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: